PANC-1(人胰腺癌细胞)

https://789.bio/ec/uSZP0K
  • https://789.bio/ec/uSZP0K
  • https://789.bio/ec/OOR4VP
  • https://789.bio/ec/pqiqPR
  • https://789.bio/ec/GVWi5G
  • https://789.bio/ec/tSpuPG
  • https://789.bio/ec/taqi1R
  • https://789.bio/ec/aDVSOR

货号: CL-0184

Price: ¥1600 ¥1600

Size:
1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

生长培养基: DMEM[PM150210]+10% FBS[164210]+1% P/S[PB180120]

产品信息

产品名称 PANC-1(人胰腺癌细胞)
别称 Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40% FBS+5% DMSO
温度:液氮
培养方案A(默认) 生长培养基:DMEM[PM150210]+10% FBS[164210]+1% P/S[PB180120]
培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃
培养方案B(可选) 生长培养基:
培养条件: 气相:, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周

参考资料(来源文献)

背景描述 这株人胰腺癌细胞株PANC-1源自于胰腺癌导管细胞。PANC-1细胞倍增时间为52小时,G6PD活性处于低泳动性的B型。染色体研究表明,PANC-1细胞模式数目为63,包括3个独特标记的染色体和1个小环状染色体。PANC-1细胞的生长可被1 U/mL的左旋天冬酰胺酶抑制;PANC-1细胞能在软琼脂上生长,亦能在裸鼠上成瘤。
年龄(性别) 56Y Male
组织来源 胰腺;胰管;上皮细胞癌
细胞类型 肿瘤细胞
肿瘤类型 胰腺癌细胞
生物安全等级 BSL-1

STR位点信息

STR鉴定图

  • Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy(2025)

    作者:Wang Wenyan, Yao Shun-Yu, Luo Jingjing, Ding Chendi, Huang Qili, Yang Yao, Shi Zhaoqing, Lin Jiachan, Pan Yu-Chen, Zeng Xiaowei, Guo Dong-Sheng, Chen Hongzhong

    期刊:Nature Communications

    DOI:10.1038/s41467-025-55905-y

    影响因子:14.7

    引用产品: MCF7 [MCF-7] 细胞, B16 细胞, CT26.WT 细胞, 4T1 细胞, PANC-1 细胞

  • Chemically engineered antibodies for autophagy-based receptor degradation(2025)

    作者:Cheng Binghua, Li Meiqing, Zheng Jiwei, Liang Jiaming, Li Yanyan, Liang Ruijing, Tian Hui, Zhou Zeyu, Ding Li, Ren Jian, Shi Wenli, Zhou Wenjie, Hu Hailiang, Meng Long, Liu Ke, Cai Lintao, Shao Ximing, Fang Lijing, Li Hongchang

    期刊:Nature Chemical Biology

    DOI:10.1038/s41589-024-01803-1

    影响因子:12.9

    引用产品: Hela 细胞, MDA-MB-231 细胞, U-87 MG 细胞, A549 [A-549] 细胞, PANC-1 细胞, NCI-H292 细胞, NCI-H1299 细胞, NCI-H1975 细胞, A-375 细胞, HuH-7 细胞, 293T [HEK-293T] 细胞

  • FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance(2025)

    作者:Liuxi Zhang, Fang Wei, Qihui Sun, Xinyan Huang, Qi Zou, Mengmeng Jiang, Yuling Su, Shu Li, Xiaojia Li, Keping Xie, Jie He

    期刊:International Journal of Biological Sciences

    DOI:10.7150/ijbs.105289

    影响因子:8.2

    引用产品: BxPC-3 细胞, CFPAC-1 细胞, MIA PaCa-2 细胞, PANC-1 细胞, Panc02 细胞, PL45 细胞

  • Fabrication of Gemcitabine and Mitoxantrone Loaded PLG/Mesoporous Silica Nanofibers: Investigation of In Vitro Drug Release and Anticancer Activity in Pancreatic Cancer Cells(2025)

    作者:Wu Hui-min, Wang Sheng-lan, Li Xin-xing, Ai Kai-xing

    期刊:BioNanoScience

    DOI:10.1007/s12668-024-01657-w

    影响因子:3.0

    引用产品: PANC-1 细胞

  • RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis(2025)

    作者:Wang Xinqing, Fan Hao, Ye Xiaoping, Hu Yu, Xiao Yan, Zhang Ming, Xu Yonghui, Song Jianjun, Luo Yongyun

    期刊:EUROPEAN JOURNAL OF MEDICAL RESEARCH

    DOI:10.1186/s40001-024-02261-0

    影响因子:2.8

    引用产品: AsPC-1 细胞, PANC-1 细胞, SW 1990 细胞, MIA PaCa-2 细胞

  • Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer(2024)

    作者:Zhou Pengcheng, Du Xuanlong, Jia Weilu, Feng Kun, Zhang Yewei

    期刊:Signal Transduction and Targeted Therapy

    DOI:10.1038/s41392-024-01872-7

    影响因子:40.8

    引用产品: DMEM/F12 培养基, 特级胎牛血清, PANC-1 细胞

  • TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770-5p axis in PDAC(2024)

    作者:Wenjie Huang, Xiaojun Hu, Xiang He, Dongyue Pan, Zhaorong Huang, Zhanfeng Gu, Guobing Huang, Ping Wang, Chunhui Cui, Yingfang Fan

    期刊:DRUG RESISTANCE UPDATES

    DOI:10.1016/j.drup.2024.101079

    影响因子:24.3

    引用产品: SW 1990 细胞, PANC-1 细胞

  • Orchestrated desaturation reprogramming from stearoyl-CoA desaturase to fatty acid desaturase 2 in cancer epithelial-mesenchymal transition and metastasis(2024)

    作者:Zhicong Chen, Yanqing Gong, Fukai Chen, Hyeon Jeong Lee, Jinqin Qian, Jing Zhao, Wenpeng Zhang, Yamin Li, Yihui Zhou, Qiaobing Xu, Yu Xia, Liqun Zhou, Ji-Xin Cheng

    期刊:Cancer Communications

    DOI:10.1002/cac2.12644

    影响因子:20.1

    引用产品: T24 [T-24] 细胞, SW 780 [SW-780, SW780] 细胞, MDA-MB-231 细胞, MCF7 [MCF-7] 细胞, PANC-1 细胞, BxPC-3 细胞, 293T [HEK-293T] 细胞

  • HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells(2024)

    作者:Luo Ziyang, Zheng Qingfang, Ye Shazhou, Li Yanguo, Chen Jiayi, Fan Chengjiang, Chen Jianing, Lei Yuxin, Liao Qi, Xi Yang

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-024-06592-y

    影响因子:9.0

    引用产品: PANC-1 细胞, MIA PaCa-2 细胞, BxPC-3 细胞

  • Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma(2024)

    作者:Tan Yan Qin, Sun Bowen, Zhang Xi, Zhang Shuwei, Guo Hui, Basappa Basappa, Zhu Tao, Sethi Gautam, Lobie Peter E., Pandey Vijay

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-024-06551-7

    影响因子:9.0

    引用产品: SW 1990 细胞, PANC-1 细胞, AsPC-1 细胞, CFPAC-1 细胞

  • Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?

    部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图

联系我们

400-999-2100

24小时服务热线

sales@procell.com.cn

销售邮箱

×
微信客服 联系我们 返回顶部
在线咨询